tm logo
OPROVDA
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 16 Oct 2024

Last Applicant/ Owned by

181 Oyster Point Boulevard

South San Francisco

CA

94080

Serial Number

97377332 filed on 22nd Apr 2022

Registration Number

N/A

Correspondent Address

Janina Gorbach

Janina Gorbach Pfizer Inc.

New York, NY 10017

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

OPROVDA

Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97377332

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T441713

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Oct 2024SOU EXTENSION 3 GRANTED
16th Oct 2024SOU EXTENSION 3 FILED
16th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Oct 2024SOU TEAS EXTENSION RECEIVED
11th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10th Apr 2024SOU EXTENSION 2 FILED
10th Apr 2024SOU EXTENSION 2 GRANTED
10th Apr 2024SOU TEAS EXTENSION RECEIVED
06th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Oct 2023SOU TEAS EXTENSION RECEIVED